An observational study in Epilepsy, Unspecified, Pharmacologically Resistant and Memory Impairment, sponsored by Institut National de la Santé Et de la Recherche Médicale, France. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-24.
Sponsored by Institut National de la Santé Et de la Recherche Médicale, France · Observational
This study has two purposes: firstly, a better understanding of the neurobiological processes underlying episodic memory and, secondly, the development of useful clinical applications for epileptic patients, in particular the prediction of postoperative memory deficits and the development of cognitive remediation therapies.
Memory performances during a fMRI experiment will be assessed in controls and epileptic patients before and after the surgery.
1,805 studies on the registry are indexed under Epilepsy; 417 are open to participants now.
This study's enrollment of 29 is below the median of 102 across 521 observational studies indexed under Epilepsy.
Browse Epilepsy studies →Institut National de la Santé Et de la Recherche Médicale, France is the lead sponsor of 375 studies on the registry; 82 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The research requires the inclusion of healthy volunteers (controls) and epileptic patients
Exclusion Criteria:
Measure of successfull encoding
Our goal is to define correlation between the measure of successfull object encoding trials (especially for binding) and the beta value activation in fMRI
Time frame: 8 years
This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut National de la Santé Et de la Recherche Médicale, France